Table 1.
Baseline patient clinical characteristics
| Baseline characteristics | All subjects, n = 179 |
|---|---|
| Age (years ± SD) | 59 (± 13) |
| Sex | |
| ȃMale | 135 (75.4%) |
| ȃFemale | 44 (24.6%) |
| Race | |
| ȃWhite | 115 (64.3%) |
| ȃBlack | 55 (30.7%) |
| ȃHispanic | 4 (2.2%) |
| ȃAsian | 4 (2.2%) |
| ȃOther | 1 (0.6%) |
| BMI (kg/m2) | 29 ± 6 |
| ICD indication | |
| ȃPrimary prevention | 101 (56.7%) |
| ȃSecondary prevention | 77 (43.3%) |
| CMR study indication | |
| ȃVentricular arrhythmia | 114 (63.7%) |
| ȃCardiomyopathy evaluation | 53 (29.6%) |
| ȃViability | 10 (5.6%) |
| ȃOther | 2 (1.1%) |
| Referral setting | |
| ȃInpatient | 62 (34.8%) |
| ȃOutpatient | 116 (64.8%) |
| Comorbidities | |
| ȃHypertension | 122 (68.2%) |
| ȃDyslipidaemia | 112 (62.6%) |
| ȃDiabetes mellitus | 56 (31.3%) |
| ȃSmoking | |
| ȃȃNever | 114 (64.0%) |
| ȃȃCurrent | 60 (33.7%) |
| ȃȃFormer | 4 (2.3%) |
| ȃChronic kidney disease | 54 (30.3%) |
| ȃPeripheral arterial disease | 16 (9.0%) |
| ȃStroke | 19 (10.7%) |
| ȃCoronary artery disease | 87 (48.9%) |
| ȃHeart failure | 151 (84.8%) |
| ȃRheumatoid arthritis | 3 (1.7%) |
| ȃAmyloidosis | 7 (4.0%) |
| ȃSarcoidosis | 8 (4.5%) |
| ȃArrhythmogenic right ventricular cardiomyopathy | 7 (3.9%) |
| ȃFamily history of atherosclerotic cardiovascular disease | 65 (36.5%) |
| ȃPrior ventricular ablation | 36 (20.9%) |